The resolution of inflammation: Principles and challenges

Seminars in Immunology

Volumn 27, Issue 3, 2015, Pages 149-160

  Headland, Sarah E ^a   Norling, Lucy V ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Efferocytosis; Microvesicles; NETs; Resolution of inflammation; Retrograde chemotaxis

Indexed keywords

APOPTOSIS; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; CLINICAL TRIAL (TOPIC); HUMAN; HYPOXIA; INFLAMMATION; MACROPHAGE; MEMBRANE MICROPARTICLE; MONOCYTE; NEUTROPHIL; NONHUMAN; REVIEW; CELL HYPOXIA; IMMUNOLOGY; MACROPHAGE ACTIVATION;

ANTIINFLAMMATORY AGENT; AUTACOID; CYTOKINE;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL HYPOXIA; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGE ACTIVATION; MACROPHAGES; NEUTROPHILS;

EID: 84937516592     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2015.03.014     Document Type: Review

References (178)

1. Withers P.C. Comparative Animal Physiology, Illustrated 1992, Saunders College Publisher, University of Michigan. Revised ed.
2. Mojica F.J., Diez-Villasenor C., Soria E., Juez G. Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Mol. Microbiol. 2000, 36(April):244-246.
3. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454(July):428-435.
4. Reville K., Crean J.K., Vivers S., Dransfield I., Godson C. Lipoxin A4 redistributes myosin IIA and Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytes. J. Immunol. 2006, 176(February):1878-1888.
5. Serhan C.N., Savill J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 2005, 6(December):1191-1197.
6. Norling L.V., Serhan C.N. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J. Intern. Med. 2010, 268(July):15-24.
7. Dalli J., Consalvo A.P., Ray V., Di Filippo C., D'Amico M., Mehta N., et al. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. J. Immunol. 2013, 190(June):6478-6487.
8. Caliendo G., Cirino G., Santagada V., Wallace J.L. Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals. J. Med. Chem. 2010, 53(September):6275-6286.
9. Dalli J., Kraft B.D., Colas R.A., Shinohara M., Fredenburgh L.E., Hess D.R., et al. Proresolving lipid mediator profiles in baboon pneumonia are regulated by inhaled carbon monoxide. Am. J. Respir. Cell Mol. Biol. 2015, January, 10.1165/rcmb.2014-0299OC.
10. Chiang N., Shinohara M., Dalli J., Mirakaj V., Kibi M., Choi A.M., et al. Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits. J. Immunol. 2013, 190(June):6378-6388.
11. Ehrentraut H., Clambey E.T., McNamee E.N., Brodsky K.S., Ehrentraut S.F., Poth J.M., et al. CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. FASEB J. 2013, 27(June 6):2207-2219.
12. Mirakaj V., Dalli J., Granja T., Rosenberger P., Serhan C.N. Vagus nerve controls resolution and pro-resolving mediators of inflammation. J. Exp. Med. 2014, 211(June):1037-1048.
13. Pavlov V.A., Tracey K.J. The vagus nerve and the inflammatory reflex - linking immunity and metabolism. Nat. Rev. Endocrinol. 2012, 8(December):743-754.
14. Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2001, 2(July):612-619.
15. Chiang N., Fredman G., Backhed F., Oh S.F., Vickery T., Schmidt B.A., et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 2012, 484(April):524-528.
16. Ramon S., Gao F., Serhan C.N., Phipps R.P. Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J. Immunol. 2012, 189(Jul):1036-1042.
17. Xu Z.Z., Liu X.J., Berta T., Park C.K., Lu N., Serhan C.N., et al. Neuroprotectin/protectin D1 protects against neuropathic pain in mice after nerve trauma. Ann. Neurol. 2013, 74(September):490-495.
18. Chiang N., Serhan C.N. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators. Methods Mol. Biol. 2006, 341:227-250.
19. Hayhoe R.P., Kamal A.M., Solito E., Flower R.J., Cooper D., Perretti M. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 2006, 107(March):2123-2130.
20. El Kebir D., Jozsef L., Khreiss T., Pan W., Petasis N.A., Serhan C.N., et al. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J. Immunol. 2007, 179(July):616-622.
21. Maderna P., Cottell D.C., Toivonen T., Dufton N., Dalli J., Perretti M., et al. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis. FASEB J. 2010, 24(November):4240-4249.
22. M. Scannell, M.B. Flanagan, A. deStefani, K.J. Wynne, G. Cagney, C., et al.,Annexin-1 and peptide derivatives are released by apoptotic cells and stim-ulate phagocytosis of apoptotic neutrophils by macrophages Godson, J.Immunol. 178 (April) (2007) 4595-4605
23. McArthur S., Cristante E., Paterno M., Christian H., Roncaroli F., Gillies G.E., et al. Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. J. Immunol. 2010, 185(November):6317-6328.
24. Paschalidis N., Iqbal A.J., Maione F., Wood E.G., Perretti M., Flower R.J., et al. Modulation of experimental autoimmune encephalomyelitis by endogenous annexin A1. J. Neuroinflamm. 2009, 6:33.
25. Gavins F.N., Dalli J., Flower R.J., Granger D.N., Perretti M. Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation. FASEB J. 2007, 21(June):1751-1758.
26. Ayoub S.S., Yazid S., Flower R.J. Increased susceptibility of annexin-A1 null mice to nociceptive pain is indicative of a spinal antinociceptive action of annexin-A1. Br. J. Pharmacol. 2008, 154(July):1135-1142.
27. Leoni G., Neumann P.A., Kamaly N., Quiros M., Nishio H., Jones H.R., et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J. Clin. Invest. 2015, 125(March):1215-1227.
28. Perretti M., Chiang N., La M., Fierro I.M., Marullo S., Getting S.J., et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 2002, 8(November):1296-1302.
29. Bena S., Brancaleone V., Wang J.M., Perretti M., Flower R.J. Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. J. Biol. Chem. 2012, 287(July):24690-24697.
30. Arita M., Ohira T., Sun Y.P., Elangovan S., Chiang N., Serhan C.N. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 2007, 178(March):3912-3917.
31. Ohira T., Arita M., Omori K., Recchiuti A., Van Dyke T.E., Serhan C.N. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J. Biol. Chem. 2010, 285(January):3451-3461.
32. Fredman G., Serhan C.N. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem. J. 2011, 437(July):185-197.
33. Wan M., Godson C., Guiry P.J., Agerberth B., Haeggstrom J.Z. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counter regulated by lipoxin A4 and resolvin E1. FASEB J. 2011, 25(May):1697-1705.
34. Athens J.W., Haab O.P., Raab S.O., Mauer A.M., Ashenbrucker H., Cartwright G.E., et al. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J. Clin. Invest. 1961, 40(June):989-995.
35. McCracken J.M., Allen L.A. Regulation of human neutrophil apoptosis and lifespan in health and disease. J. Cell Death 2014, 7:15-23.
36. Harty M.W., Muratore C.S., Papa E.F., Gart M.S., Ramm G.A., Gregory S.H., et al. Neutrophil depletion blocks early collagen degradation in repairing cholestatic rat livers. Am. J. Pathol. 2010, 176(March):1271-1281.
37. Kuhl A.A., Kakirman H., Janotta M., Dreher S., Cremer P., Pawlowski N.N., et al. Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 2007, 133(December):1882-1892.
38. Campbell E.L., Bruyninckx W.J., Kelly C.J., Glover L.E., McNamee E.N., Bowers B.E., et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 2014, 40(January):66-77.
39. Gastardelo T.S., Damazo A.S., Dalli J., Flower R.J., Perretti M., Oliani S.M. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am. J. Pathol. 2009, 174(January):177-183.
40. Perretti M., Flower R.J. Annexin 1 and the biology of the neutrophil. J. Leukoc. Biol. 2004, 76(July):25-29.
41. Schauer C., Janko C., Munoz L.E., Zhao Y., Kienhofer D., Frey B., et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat. Med. 2014, 20(May):511-517.
42. Gresnigt M.S., Joosten L.A., Verschueren I., van der Meer J.W., Netea M.G., Dinarello C.A., et al. Neutrophil-mediated inhibition of proinflammatory cytokine responses. J. Immunol. 2012, 189(November):4806-4815.
43. Iqbal A.J., McNeill E., Kapellos T.S., Regan-Komito D., Norman S., Burd S., et al. Human CD68 promoter directs GFP transgene expression in mouse myeloid cells, allowing analysis of monocyte to macrophage differentiation in vivo. Blood 2014, 124(July).
44. Bystrom J., Evans I., Newson J., Stables M., Toor I., van Rooijen N., et al. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 2008, 112(November):4117-4127.
45. Stables M.J., Shah S., Camon E.B., Lovering R.C., Newson J., Bystrom J., et al. Transcriptomic analyses of murine resolution-phase macrophages. Blood 2011, 118(December):e192-e208.
46. Sitkovsky M., Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat. Rev. Immunol. 2005, 5(September):712-721.
47. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112(March):645-657.
48. Karhausen J., Furuta G.T., Tomaszewski J.E., Johnson R.S., Colgan S.P., Haase V.H. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 2004, 114(October):1098-1106.
49. Robinson A., Keely S., Karhausen J., Gerich M.E., Furuta G.T., Colgan S.P. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 2008, 134(January):145-155.
50. Watkins L.R., Goehler L.E., Relton J.K., Tartaglia N., Silbert L., Martin D., et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci. Lett. 1995, 183(January):27-31.
51. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405(May):458-462.
52. Andersson U., Tracey K.J. Neural reflexes in inflammation and immunity. J. Exp. Med. 2012, 209(June):1057-1068.
53. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 2004, 10(November):1216-1221.
54. van Maanen M.A., Stoof S.P., Larosa G.J., Vervoordeldonk M.J., Tak P.P. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. Ann. Rheum. Dis. 2010, 69(September):1717-1723.
55. van Maanen M.A., Lebre M.C., van der Poll T., LaRosa G.J., Elbaum D., Vervoordeldonk M.J., et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 2009, 60(January):114-122.
56. van Maanen M.A., Vervoordeldonk M.J., Tak P.P. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat. Rev. Rheumatol. 2009, 5(April):229-232.
57. Evrengul H., Dursunoglu D., Cobankara V., Polat B., Seleci D., Kabukcu S., et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol. Int. 2004, 24(July):198-202.
58. Goldstein R.S., Bruchfeld A., Yang L., Qureshi A.R., Gallowitsch-Puerta M., Patel N.B., et al. Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 2007, 13(March-April):210-215.
59. Aherne C.M., Collins C.B., Eltzschig H.K. Netrin-1 guides inflammatory cell migration to control mucosal immune responses during intestinal inflammation. Tissue Barriers 2013, 1(April):e24957.
60. Rosenberger P., Schwab J.M., Mirakaj V., Masekowsky E., Mager A., Morote-Garcia J.C., et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 2009, 10(February):195-202.
61. Gasser O., Schifferli J.A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 2004, 104(October):2543-2548.
62. Dalli J., Montero Melendez T., Norling L.V., Yin X., Hinds C., Haskard D., et al. Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties. Mol. Cell. Proteomics 2013, 12(May):2205-2219.
63. Dalli J., Norling L.V., Renshaw D., Cooper D., Leung K.Y., Perretti M. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood 2008, 112(September):2512-2519.
64. Dalli J., Norling L.V., Montero-Melendez T., Canova D.F., Lashin H., Pavlov A.M., et al. Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis. EMBO Mol. Med. 2014, 6(January):27-42.
65. Norling L.V., Spite M., Yang R., Flower R.J., Perretti M., Serhan C.N. Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. J. Immunol. 2011, 186(May):5543-5547.
66. Dalli J., Serhan C.N. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 2012, 120(October):e60-e72.
67. Fourcade O., Simon M.F., Viode C., Rugani N., Leballe F., Ragab A., et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995, 80(March):919-927.
68. Hung N.D., Kim M.R., Sok D.E. 2-Polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice. Lipids 2011, 46(October):893-906.
69. Eken C., Gasser O., Zenhaeusern G., Oehri I., Hess C., Schifferli J.A. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. J. Immunol. 2008, 180(January):817-824.
70. Pliyev B.K., Kalintseva M.V., Abdulaeva S.V., Yarygin K.N., Savchenko V.G. Neutrophil microparticles modulate cytokine production by natural killer cells. Cytokine 2014, 65(February):126-129.
71. Eken C., Sadallah S., Martin P.J., Treves S., Schifferli J.A. Ectosomes of polymorphonuclear neutrophils activate multiple signaling pathways in macrophages. Immunobiology 2013, 218(March):382-392.
72. Eken C., Martin P.J., Sadallah S., Treves S., Schaller M., Schifferli J.A. Ectosomes released by polymorphonuclear neutrophils induce a MerTK-dependent anti-inflammatory pathway in macrophages. J. Biol. Chem. 2010, 285(December):39914-39921.
73. Lucas C.D., Hoodless L.J., Rossi A.G. Swimming against the tide: drugs drive neutrophil reverse migration. Sci. Transl. Med. 2014, 6(February):225fs9.
74. Buckley C.D., Ross E.A., McGettrick H.M., Osborne C.E., Haworth O., Schmutz C., et al. Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J. Leukoc. Biol. 2006, 79(February):303-311.
75. Woodfin A., Voisin M.B., Beyrau M., Colom B., Caille D., Diapouli F.M., et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat. Immunol. 2011, 12(August):761-769.
76. Mathias J.R., Perrin B.J., Liu T.X., Kanki J., Look A.T., Huttenlocher A. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J. Leukoc. Biol. 2006, 80(December):1281-1288.
77. Robertson A.L., Holmes G.R., Bojarczuk A.N., Burgon J., Loynes C.A., Chimen M., et al. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism. Sci. Transl. Med. 2014, 6(February):225ra29.
78. Tak T., Tesselaar K., Pillay J., Borghans J.A., Koenderman L. What's your age again? Determination of human neutrophil half-lives revisited. J. Leukoc. Biol. 2013, 94(October):595-601.
79. Lee A., Whyte M.K., Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 1993, 54(October):283-288.
80. Colotta F., Re F., Polentarutti N., Sozzani S., Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992, 80(October):2012-2020.
81. Sabroe I., Dower S.K., Whyte M.K. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin. Infect. Dis. 2005, 7(November):S421-S426.
82. Hannah S., Mecklenburgh K., Rahman I., Bellingan G.J., Greening A., Haslett C., et al. Hypoxia prolongs neutrophil survival in vitro. FEBS Lett. 1995, 372(September):233-237.
83. Mecklenburgh K.I., Walmsley S.R., Cowburn A.S., Wiesener M., Reed B.J., Upton P.D., et al. Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis. Blood 2002, 100(October):3008-3016.
84. Walmsley S.R., Print C., Farahi N., Peyssonnaux C., Johnson R.S., Cramer T., et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J. Exp. Med. 2005, 201(January):105-115.
85. Peyssonnaux C., Datta V., Cramer T., Doedens A., Theodorakis E.A., Gallo R.L., et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Investig. 2005, 115(July):1806-1815.
86. Walmsley S.R., Cowburn A.S., Clatworthy M.R., Morrell N.W., Roper E.C., Singleton V., et al. Neutrophils from patients with heterozygous germline mutations in the von Hippel Lindau protein (pVHL) display delayed apoptosis and enhanced bacterial phagocytosis. Blood 2006, 108(November):3176-3178.
87. Elks P.M., van Eeden F.J., Dixon G., Wang X., Reyes-Aldasoro C.C., Ingham P.W., et al. Activation of hypoxia-inducible factor-1alpha (Hif-1alpha) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. Blood 2011, 118(July):712-722.
88. Burgon J., Robertson A.L., Sadiku P., Wang X., Hooper-Greenhill E., Prince L.R., et al. Serum and glucocorticoid-regulated kinase 1 regulates neutrophil clearance during inflammation resolution. J. Immunol. 2014, 192(February):1796-1805.
89. Renshaw S.A., Timmons S.J., Eaton V., Usher L.R., Akil M., Bingle C.D., et al. Inflammatory neutrophils retain susceptibility to apoptosis mediated via the Fas death receptor. J. Leukoc. Biol. 2000, 67(May):662-668.
90. Liles W.C., Kiener P.A., Ledbetter J.A., Aruffo A., Klebanoff S.J. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 1996, 184(August):429-440.
91. Ward C., Chilvers E.R., Lawson M.F., Pryde J.G., Fujihara S., Farrow S.N., et al. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem. 1999, 274(February):4309-4318.
92. Murray J., Barbara J.A., Dunkley S.A., Lopez A.F., Van Ostade X., Condliffe A.M., et al. Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 1997, 90(October):2772-2783.
93. McGrath E.E., Marriott H.M., Lawrie A., Francis S.E., Sabroe I., Renshaw S.A., et al. TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J. Leukoc. Biol. 2011, 90(November):855-865.
94. Renshaw S.A., Parmar J.S., Singleton V., Rowe S.J., Dockrell D.H., Dower S.K., et al. Acceleration of human neutrophil apoptosis by TRAIL. J. Immunol. 2003, 170(January):1027-1033.
95. Rowe S.J., Allen L., Ridger V.C., Hellewell P.G., Whyte M.K. Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J. Immunol. 2002, 169(December):6401-6407.
96. Rossi A.G., Sawatzky D.A., Walker A., Ward C., Sheldrake T.A., Riley N.A., et al. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 2006, 12(September):1056-1064.
97. Kennedy A.D., DeLeo F.R. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 2009, 43:25-61.
98. Ortega-Gomez A., Perretti M., Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol. Med. 2013, 5(April):661-674.
99. Potez S., Luginbuhl M., Monastyrskaya K., Hostettler A., Draeger A., Babiychuk E.B. Tailored protection against plasmalemmal injury by annexins with different Ca2+ sensitivities. J. Biol. Chem. 2011, 286(May):17982-17991.
100. Blume K.E., Soeroes S., Keppeler H., Stevanovic S., Kretschmer D., Rautenberg M., et al. Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic find-me signal. J. Immunol. 2012, 188(January):135-145.
101. Hoffmann P.R., Kench J.A., Vondracek A., Kruk E., Daleke D.L., Jordan M., et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J. Immunol. 2005, 174(February):1393-1404.
102. Huynh M.L., Fadok V.A., Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Investig. 2002, 109(January):41-50.
103. Li M.O., Sarkisian M.R., Mehal W.Z., Rakic P., Flavell R.A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 2003, 302(November):1560-1563.
104. Csoka B., Selmeczy Z., Koscso B., Nemeth Z.H., Pacher P., Murray P.J., et al. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J. 2012, 26(January):376-386.
105. Gilroy D.W., Lawrence T., Perretti M., Rossi A.G. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 2004, 3(May):401-416.
106. Schif-Zuck S., Gross N., Assi S., Rostoker R., Serhan C.N., Ariel A. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 2011, 41(February):366-379.
107. Rossol M., Heine H., Meusch U., Quandt D., Klein C., Sweet M.J., et al. LPS-induced cytokine production in human monocytes and macrophages. Crit. Rev. Immunol. 2011, 31:379-446.
108. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140(March):871-882.
109. Tani Y., Isobe Y., Imoto Y., Segi-Nishida E., Sugimoto Y., Arai H., et al. Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice. FASEB J. 2014, June.
110. Wu D., Molofsky A.B., Liang H.E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332(April):243-247.
111. Yamada T., Tani Y., Nakanishi H., Taguchi R., Arita M., Arai H. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J. 2011, 25(February):561-568.
112. Lintermans L.L., Stegeman C.A., Heeringa P., Abdulahad W.H. T cells in vascular inflammatory diseases. Front. Immunol. 2014, 5:504.
113. Wang X., Zhu M., Hjorth E., Cortes-Toro V., Eyjolfsdottir H., Graff C., et al. Resolution of inflammation is altered in Alzheimer's disease. Alzheimers Dement. 2015, 11(January). 40-50 e1-2.
114. Fredman G., Oh S.F., Ayilavarapu S., Hasturk H., Serhan C.N., Van Dyke T.E. Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1. PLoS ONE 2011, 6:e24422.
115. Ho K.J., Spite M., Owens C.D., Lancero H., Kroemer A.H., Pande R., et al. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am. J. Pathol. 2010, 177(October):2116-2123.
116. Miyata J., Fukunaga K., Iwamoto R., Isobe Y., Niimi K., Takamiya R., et al. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J. Allergy Clin. Immunol. 2013, 131(February). 353-360 e1-2.
117. Claria J., Nguyen B.T., Madenci A.L., Ozaki C.K., Serhan C.N. Diversity of lipid mediators in human adipose tissue depots. Am. J. Physiol. Cell Physiol. 2013, 304(June):C1141-C1149.
118. Bannenberg G.L., Chiang N., Ariel A., Arita M., Tjonahen E., Gotlinger K.H., et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 2005, 174(April):4345-4355.
119. Navarro-Xavier R.A., Newson J., Silveira V.L., Farrow S.N., Gilroy D.W., Bystrom J. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J. Immunol. 2010, 184(February):1516-1525.
120. Tomasdottir V., Vikingsson A., Hardardottir I., Freysdottir J. Murine antigen-induced inflammation - a model for studying induction, resolution and the adaptive phase of inflammation. J. Immunol. Methods 2014, 415(September):36-45.
121. Gittens B.R., Wright R.D., Cooper D. Methods for assessing the effects of galectins on leukocyte trafficking. Methods Mol. Biol. 2015, 1207:133-151.
122. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005, 4(January):35-44.
123. Amsterdam A., Burgess S., Golling G., Chen W., Sun Z., Townsend K., et al. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 1999, 13(October):2713-2724.
124. Patton E.E., Zon L.I. The art and design of genetic screens: zebrafish. Nat. Rev. Genet. 2001, 2(December):956-966.
125. Trede N.S., Langenau D.M., Traver D., Look A.T., Zon L.I. The use of zebrafish to understand immunity. Immunity 2004, 20(April):367-379.
126. de Jong J.L., Zon L.I. Use of the zebrafish system to study primitive and definitive hematopoiesis. Annu. Rev. Genet. 2005, 39:481-501.
127. Crowhurst M.O., Layton J.E., Lieschke G.J. Developmental biology of zebrafish myeloid cells. Int. J. Dev. Biol. 2002, 46:483-492.
128. Onnebo S.M., Yoong S.H., Ward A.C. Harnessing zebrafish for the study of white blood cell development and its perturbation. Exp. Hematol. 2004, 32(September):789-796.
129. Redd M.J., Kelly G., Dunn G., Way M., Martin P. Imaging macrophage chemotaxis in vivo: studies of microtubule function in zebrafish wound inflammation. Cell Motil. Cytoskelet. 2006, 63(July):415-422.
130. Tharp W.G., Yadav R., Irimia D., Upadhyaya A., Samadani A., Hurtado O., et al. Neutrophil chemorepulsion in defined interleukin-8 gradients in vitro and in vivo. J. Leukoc. Biol. 2006, 79(March):539-554.
131. Lokuta M.A., Huttenlocher A. TNF-alpha promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway. J. Leukoc. Biol. 2005, 78(July):210-219.
132. Stirling D.P., Liu S., Kubes P., Yong V.W. Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J. Neurosci. 2009, 29(January):753-764.
133. Jaeger B.N., Donadieu J., Cognet C., Bernat C., Ordonez-Rueda D., Barlogis V., et al. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J. Exp. Med. 2012, 209(March):565-580.
134. De Santo C., Arscott R., Booth S., Karydis I., Jones M., Asher R., et al. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat. Immunol. 2010, 11(November):1039-1046.
135. Glowacka E., Lewkowicz P., Rotsztejn H., Zalewska A. IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils-fibroblasts interaction in psoriasis. Adv. Med. Sci. 2010, 55:254-260.
136. Davey M.S., Tamassia N., Rossato M., Bazzoni F., Calzetti F., Bruderek K., et al. Failure to detect production of IL-10 by activated human neutrophils. Nat. Immunol. 2011, 12(November):1017-1018. author reply 1018-20.
137. Tamassia N., Zimmermann M., Castellucci M., Ostuni R., Bruderek K., Schilling B., et al. Cutting edge: an inactive chromatin configuration at the IL-10 locus in human neutrophils. J. Immunol. 2013, 190(March):1921-1925.
138. Kasten K.R., Muenzer J.T., Caldwell C.C. Neutrophils are significant producers of IL-10 during sepsis. Biochem. Biophys. Res. Commun. 2010, 393(February):28-31.
139. Doz E., Lombard R., Carreras F., Buzoni-Gatel D., Winter N. Mycobacteria-infected dendritic cells attract neutrophils that produce IL-10 and specifically shut down Th17 CD4T cells through their IL-10 receptor. J. Immunol. 2013, 191(October):3818-3826.
140. Ocuin L.M., Bamboat Z.M., Balachandran V.P., Cavnar M.J., Obaid H., Plitas G., et al. Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis. J. Leukoc. Biol. 2011, 89(March):423-432.
141. Gyorgy B., Szabo T.G., Turiak L., Wright M., Herczeg P., Ledeczi Z., et al. Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLoS ONE 2012, 7:e49726.
142. Nilsson J., Skog J., Nordstrand A., Baranov V., Mincheva-Nilsson L., Breakefield X.O., et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br. J. Cancer 2009, 100(May):1603-1607.
143. van der Pol E., Boing A.N., Harrison P., Sturk A., Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 2012, 64(July):676-705.
144. Headland S.E., Jones H.R., D'Sa A.S., Perretti M., Norling L.V. Cutting-edge analysis of extracellular microparticles using imagestream(X) imaging flow cytometry. Sci. Rep. 2014, 4:5237.
145. Robert S., Lacroix R., Poncelet P., Harhouri K., Bouriche T., Judicone C., et al. High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles-brief report. Arterioscler. Thromb. Vasc. Biol. 2012, 32(April):1054-1058.
146. Rousseau M., Belleannee C., Duchez A.C., Cloutier N., Levesque T., Jacques F., et al. Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLOS ONE 2015, 10:e0116812.
147. Erdbrugger U., Rudy C.K., Dryden E.E.M.K.A., Yeager M., Klibanov A.L., et al. Imaging flow cytometry elucidates limitations of microparticle analysis by conventional flow cytometry. Cytometry A 2014, 85(September):756-770.
148. Combes V., Coltel N., Alibert M., van Eck M., Raymond C., Juhan-Vague I., et al. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am. J. Pathol. 2005, 166(January):295-302.
149. Jakubzick C., Gautier E.L., Gibbings S.L., Sojka D.K., Schlitzer A., Johnson T.E., et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 2013, 39(September):599-610.
150. Krishnamoorthy S., Recchiuti A., Chiang N., Yacoubian S., Lee C.H., Yang R., et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(January):1660-1665.
151. Norling L.V., Dalli J., Flower R.J., Serhan C.N., Perretti M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler. Thromb. Vasc. Biol. 2012, 32(August):1970-1978.
152. Hasturk H., Kantarci A., Ohira T., Arita M., Ebrahimi N., Chiang N., et al. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J. 2006, 20(February):401-403.
153. Ishida T., Yoshida M., Arita M., Nishitani Y., Nishiumi S., Masuda A., et al. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflamm. Bowel Dis. 2010, 16(January):87-95.
154. Keyes K.T., Ye Y., Lin Y., Zhang C., Perez-Polo J.R., Gjorstrup P., et al. Resolvin E1 protects the rat heart against reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2010, 299(July):H153-H164.
155. Levy B.D., Kohli P., Gotlinger K., Haworth O., Hong S., Kazani S., et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 2007, 178(January):496-502.
156. Haworth O., Cernadas M., Yang R., Serhan C.N., Levy B.D. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 2008, 9(August):873-879.
157. Connor K.M., SanGiovanni J.P., Lofqvist C., Aderman C.M., Chen J., Higuchi A., et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 2007, 13(July):868-873.
158. LeMieux M.J., Kalupahana N.S., Scoggin S., Moustaid-Moussa N. Eicosapentaenoic Acid reduces adipocyte hypertrophy and inflammation in diet-induced obese mice in an adiposity-independent manner. J. Nutr. 2015, 145(March):411-417.
159. Kavazos K., Nataatmadja M., Wales K.M., Hartland E., Williams C., Russell F.D. Dietary supplementation with omega-3 polyunsaturated fatty acids modulate matrix metalloproteinase immunoreactivity in a mouse model of pre-abdominal aortic aneurysm. Heart Lung Circ. 2014, 24(November):377-385.
160. Piazzi G., D'Argenio G., Prossomariti A., Lembo V., Mazzone G., Candela M., et al. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota. Int. J. Cancer 2014, 135(November):2004-2013.
161. Naqvi A.Z., Hasturk H., Mu L., Phillips R.S., Davis R.B., Halem S., et al. Docosahexaenoic acid and periodontitis in adults: a randomized controlled trial. J. Dent. Res. 2014, 93(June):767-773.
162. Shinto L., Quinn J., Montine T., Dodge H.H., Woodward W., Baldauf-Wagner S., et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J. Alzheimers Dis. 2014, 38:111-120.
163. Scorletti E., Bhatia L., McCormick K.G., Clough G.F., Nash K., Hodson L., et al. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. Hepatology 2014, 60(October):1211-1221.
164. Miles E.A., Calder P.C. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br. J. Nutr. 2012, 107(June (Suppl. 2)):S171-S184.
165. Chiang N., Serhan C.N., Dahlen S.E., Drazen J.M., Hay D.W., Rovati G.E., et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 2006, 58(September):463-487.
166. Maderna P., Yona S., Perretti M., Godson C. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J. Immunol. 2005, 174:3727-3733.
167. Schwab J.M., Chiang N., Arita M., Serhan C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447(June):869-874.
168. Godson C., Mitchell S., Harvey K., Petasis N.A., Hogg N., Brady H.R. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 2000, 164(February):1663-1667.
169. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 2000, 192(October):1197-1204.
170. Hasturk H., Kantarci A., Goguet-Surmenian E., Blackwood A., Andry C., Serhan C.N., et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J. Immunol. 2007, 179(November):7021-7029.
171. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8(May):349-361.
172. Marcheselli V.L., Mukherjee P.K., Arita M., Hong S., Antony R., Sheets K., et al. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82(January):27-34.
173. Park C.K., Lu N., Xu Z.Z., Liu T., Serhan C.N., Ji R.R. Resolving TRPV1- and TNF-alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J. Neurosci. 2011, 31(October):15072-15085.
174. Serhan C.N., Gotlinger K., Hong S., Lu Y., Siegelman J., Baer T., et al. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 2006, 176(February):1848-1859.
175. Ye R.D., Boulay F., Wang J.M., Dahlgren C., Gerard C., Parmentier M., et al. International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 2009, 61(June):119-161.
176. Marcon R., Bento A.F., Dutra R.C., Bicca M.A., Leite D.F., Calixto J.B. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. J. Immunol. 2013, 191(October):4288-4298.
177. Serhan C.N., Yang R., Martinod K., Kasuga K., Pillai P.S., Porter T.F., et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 2009, 206(January):15-23.
178. Wittamer V., Gregoire F., Robberecht P., Vassart G., Communi D., Parmentier M. The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J. Biol. Chem. 2004, 279(March):9956-9962.